Silk fibroin added to calcium phosphate cement to prevent severe cardiovascular complications

Case Reports and Clinical Practice Review

Volumn 16, Issue 9, 2010, Pages 23-26

  Ding, Tao ^a,b   Yang, Huilin ^a   Maltenfort, Mitchell ^c   Xie, Ruijuan ^d  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

Calcium phosphate cement; Cardiovascular complications; Kyphoplasty; Vertebroplasty

Indexed keywords

BONE CEMENT; CALCIUM PHOSPHATE; SILK FIBROIN; BIOMATERIAL; HYDROXYAPATITE; FIBROIN;

ACIDEMIA; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BONE DEFECT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERCAPNIA; HYPOXEMIA; KYPHOPLASTY; LUNG EMBOLISM; NONHUMAN; PERCUTANEOUS VERTEBROPLASTY; PULMONARY HYPERTENSION; RISK REDUCTION; THORAX RADIOGRAPHY; TISSUE ENGINEERING; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOMECHANICS; GELATION; MINERALIZATION; ANIMAL; CHEMISTRY;

ANIMALS; BONE CEMENTS; CALCIUM PHOSPHATES; CARDIOVASCULAR DISEASES; FIBROINS; HUMANS; KYPHOPLASTY; PULMONARY EMBOLISM;

EID: 77956949193     PISSN: 15076164     EISSN: 16433742     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. McGraw JK, Lippert JA, Minkus KD et al: Prospective evaluation of pain relief in 100 patients undergoing percutaneous vertebroplasty: results and follow-up. J Vasc Interv Radiol, 2002; 13: 883-886
2. Bostrom MP, Lane JM: Future directions. Augmentation of osteoporotic vertebral bodies. Spine (Phila Pa 1976), 1997; 22: 38S-42S
3. Jensen ME, Evans AJ, Mathis JM et al: Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects. AJNR Am J Neuroradiol, 1997; 18: 1897-1904
4. Dahl OE, Garvik LJ, Lyberg T: Toxic effects of methylmethacrylate monomer on leukocytes and endothelial cells in vitro. Acta Orthop Scand, 1994; 65: 147-53
5. Deramond H, Wright NT, Belkoff SM: Temperature elevation caused by bone cement polymerization during vertebroplasty. Bone, 1999; 25: 17S-21S
6. Konno S, Olmarker K, Byrod G et al: The European Spine Society AcroMed Prize 1994. Acute thermal nerve root injury. Eur Spine J, 1994; 3: 299-302
7. Polikeit A, Nolte LP, Ferguson SJ: The effect of cement augmentation on the load transfer in an osteoporotic functional spinal unit: finite-element analysis. Spine (Phila Pa 1976), 2003; 28: 991-96
8. Matsuyama Y, Goto M, Yoshihara H et al: Vertebral reconstruction with biodegradable calcium phosphate cement in the treatment of osteoporotic vertebral compression fracture using instrumentation. J Spinal Disord Tech, 2004; 17: 291-96
9. Nakano M, Hirano N, Matsuura K et al: Percutaneous transpedicular vertebroplasty with calcium phosphate cement in the treatment of osteoporotic vertebral compression and burst fractures. J Neurosurg, 2002; 97: 287-293
10. Verlaan JJ, van Helden WH, Oner FC et al: Balloon vertebroplasty with calcium phosphate cement augmentation for direct restoration of traumatic thoracolumbar vertebral fractures. Spine (Phila Pa 1976), 2002; 27: 543-548
11. Kurashina K, Kurita H, Hirano M et al: Calcium phosphate cement: in vitro and in vivo studies of the -tricalcium phosphate-dicalcium phosphate dibasic-tetracalcium phosphate monoxide system. J Mater Sci Mater Med, 1995; 6: 340-347
12. Krebs J, Aebli N, Goss BG et al: Cardiovascular changes after pulmonary embolism from injecting calcium phosphate cement. J Biomed Mater Res B Appl Biomater, 2007; 82: 526-32
13. Bernards J, Mirza S: Lethality of embolized norian bone cement varies with the time between mixing and embolization. Transactions of the 50th Annual Meeting of the Orthopaedic Research Society, 2004; 254
14. Jang JS, Lee SH, Jung SK: Pulmonary embolism of polymethylmethacrylate after percutaneous vertebroplasty: a report of three cases. Spine, 2002; 27: E416-E418
15. Moreland DB, Landi MK, Grand W: Vertebroplasty: techniques to avoid complications. Spine J, 2001; 1: 66-71
16. Amar AP, Larsen DW, Esnaashari N et al: Percutaneous transpedicular polymethyl methacrylate vertebroplasty for the treatment of spinal compression fractures. Neurosurgery, 2001; 49: 1105-1114
17. Vasconcelos C, Gailloud P, Beauchamp NJ et al: Is percutaneous vertebroplasty without pretreatment venography safe? Evaluation of 205 consecutives procedures. AJNR Am J Neuroradiol, 2002; 23: 913-917
18. Tozzi P, Abdelmoumene Y, Corno AF et al: Management of pulmonary embolism during acrylic vertebroplasty. Ann Thorac Surg, 2002; 74: 1706-1708
19. Charvet A, Metellus P, Bruder N et al: [Pulmonary embolism of cement during vertebroplasty]. Ann Fr Anesth Reanim, 2004; 23: 827-830
20. Yoo KY, Jeong SW, Yoon W, Lee J: Acute respiratory distress syndrome associated with pulmonary cement embolism following percutaneous vertebroplasty with polymethylmethacrylate. Spine (Phila Pa 1976), 2004; 29: E294-E297
21. Padovani B, Kasriel O, Brunner P, Peretti-Viton P: Pulmonary embolism caused by acrylic cement: A rare complication of percutaneous vertebroplasty. Am J Neuroradiol, 1999; 20: 375-377
22. Kostadima E, Zakynthinos E: Pulmonary embolism: pathophysiology, diagnosis, treatment. Hellenic J Cardiol, 2007; 48: 94-107
23. Hyland JW, Smith GT, Mc GL et al: Effect of selective embolization of various sized pulmonary arteriesin dogs. Am J Physiol 1963; 204: 619-625
24. Binder AS, Kageler W, Perel A et al: Effect of platelet depletion on lung vascular permeability after microemboli in sheep. J Appl Physiol, 1980; 48: 414-420
25. Malik AB, van der Zee H: Time course of pulmonary vascular response to microembolization. J Appl Physiol, 1977; 43: 51-58
26. Alpert JS, Haynes FW, Dalen JE, Dexter L: Experimental pulmonary embolism; effect on pulmonary blood volume and vascular compliance. Circulation, 1974; 49: 152-157
27. Ohkuda K, Nakahara K, Weidner WJ et al: Lung fluid exchange after uneven pulmonary artery obstruction in sheep. Circ Res, 1978; 43: 152-161
28. Malik AB: Pulmonary microembolism. Physiol Rev, 1983; 63: 1114-207
29. Kikuchi M, Itoh S, Ichinose S et al: Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo. Biomaterials, 2001; 22: 1705-1711
30. Chang M, Ikoma T, Kikuchi M, Tanaka J: Preparation of a porous hydroxyapatite/collagen nanocomposite using glutaraldehyde as a crosslinkage agent. J Mater Sci Lett, 2001; 20: 1199-1201
31. Bigi A, Bracci B, Panzavolta S: Effect of added gelatin on the properties of calcium phosphate cement. Biomaterials, 2004; 25: 2893-2899
32. Xu HH, Takagi S, Quinn JB, Chow LC: Fast-setting calcium phosphate scaffolds with tailored macropore formation rates for bone regeneration. J Biomed Mater Res A, 2004; 68: 725-734
33. Cherng A, Takagi S, Chow LC: Effects of hydroxypropyl methylcellulose and other gelling agents on the handling properties of calcium phosphate cement. J Biomed Mater Res, 1997; 35: 273-277
34. Takagi S, Chow LC, Hirayama S, Eichmiller FC: Properties of elastomeric calcium phosphate cement-chitosan composites. Dent Mater, 2003; 19: 797-804
35. Takechi M, Miyamoto Y, Ishikawa K et al: Non-decay type fast-setting calcium phosphate cement using chitosan. J Mater Sci Mater Med, 1996; 7: 317-322
36. Ishikawa K, Miyamoto Y, Takechi M et al: Non-decay type fast-setting calcium phosphate cement: hydroxyapatite putty containing an increased amount of sodium alginate. J Biomed Mater Res, 1997; 36: 393-399
37. Miyamoto Y, Ishikawa K, Takechi M et al: Non-decay type fast-setting calcium phosphate cement: setting behaviour in calf serum and its tissue response. Biomaterials, 1996; 17: 1429-1435
38. Ishikawa K, Miyamoto Y, Kon M et al: Non-decay type fast-setting calcium phosphate cement: composite with sodium alginate. Biomaterials, 1995; 16: 527-532
39. Kong X, Cui F, Wang X et al: Silk fibroin regulated mineralization of hydroxyapatite nanocrystals. J Cryst Growth, 2004; 270: 197-202
40. Wang L, Ning G, Senna M: Microstructure and gelation behavior of hydroxyapatite- based nanocomposite sol containing chemically modified silk fibroin. Colloids Surf A Physicochem Eng Asp, 2005; 254: 159-14
41. Li M, Ogiso M, Minoura N: Enzymatic degradation behavior of porous silk fibroin sheets. Biomaterials, 2003; 24: 357-35
42. Altman GH, Diaz F, Jakuba C et al: Silk-based biomaterials. Biomaterials, 2003; 24: 401-46
43. Panilaitis B, Altman GH, Chen J et al: Macrophage responses to silk. Biomaterials, 2003; 24: 3079-3085
44. Chiarini A, Petrini P, Bozzini S et al: Silk fibroin/poly(carbonate)-urethane as a substrate for cell growth: in vitro interactions with human cells. Biomaterials, 2003; 24: 789-799
45. Altman GH, Horan RL, Lu HH et al: Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials, 2002; 23: 4131-4141
46. Meinel L, Fajardo R, Hofmann S et al: Silk implants for the healing of critical size bone defects. Bone, 2005; 37: 688-698
47. Wang G, Yang H, Li M et al: The use of silk fibroin/hydroxyapatite composite co-cultured with rabbit bone-marrow stromal cells in the healing of a segmental bone defect. J Bone Joint Surg Br, 2010; 92: 320-325